Works by Nakajima, Takako Eguchi
Results: 58
Phase II study of cetuximab with irinotecan for KRAS wild-type colorectal cancer in Japanese patients.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 2, p. e132, doi. 10.1111/ajco.12405
- By:
- Publication type:
- Article
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 2, p. 199, doi. 10.1093/jjco/hyaa190
- By:
- Publication type:
- Article
Co-operative groups in the development of chemotherapy for gastric cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 3, p. 210, doi. 10.1093/jjco/hyy176
- By:
- Publication type:
- Article
A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 11, p. 1002, doi. 10.1093/jjco/hyx114
- By:
- Publication type:
- Article
Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2021, v. 28, n. 1, p. 1, doi. 10.1002/jhbp.868
- By:
- Publication type:
- Article
Reply to L. Celio et al.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 10, p. 1897, doi. 10.1038/s41416-023-02212-2
- By:
- Publication type:
- Article
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild‐type metastatic colorectal cancer: A phase II trial (HYBRID).
- Published in:
- Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7107
- By:
- Publication type:
- Article
Current Status and Issues of the Japan Oncofertility Registry.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2023, v. 12, n. 4, p. 584, doi. 10.1089/jayao.2022.0110
- By:
- Publication type:
- Article
Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 4599, doi. 10.2147/OTT.S106101
- By:
- Publication type:
- Article
Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment.
- Published in:
- Nutrition & Cancer, 2022, v. 74, n. 2, p. 539, doi. 10.1080/01635581.2021.1902542
- By:
- Publication type:
- Article
How to select and understand guidelines for patient-reported outcomes: a scoping review of existing guidance.
- Published in:
- BMC Health Services Research, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12913-024-10707-8
- By:
- Publication type:
- Article
Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical Implications of Decreased Computed Tomography Value after Ramucirumab in Advanced Gastric Cancer.
- Published in:
- Oncology, 2019, v. 97, n. 2, p. 94, doi. 10.1159/000500326
- By:
- Publication type:
- Article
Perceptions regarding the concept and definition of patient-reported outcomes among healthcare stakeholders in Japan with relation to quality of life: a cross-sectional study.
- Published in:
- Health & Quality of Life Outcomes, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12955-023-02224-9
- By:
- Publication type:
- Article
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08).
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 235, doi. 10.1007/s10120-021-01237-x
- By:
- Publication type:
- Article
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 467, doi. 10.1007/s10120-020-01131-y
- By:
- Publication type:
- Article
Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G).
- Published in:
- Gastric Cancer, 2020, v. 23, n. 4, p. 677, doi. 10.1007/s10120-020-01043-x
- By:
- Publication type:
- Article
Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 6, p. 1238, doi. 10.1007/s10120-019-00973-5
- By:
- Publication type:
- Article
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 344, doi. 10.1007/s10120-018-0899-6
- By:
- Publication type:
- Article
Management of adjuvant S-1 therapy after curative resection of gastric cancer: dose reduction and treatment schedule modification.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 28, doi. 10.1007/s10120-011-0003-y
- By:
- Publication type:
- Article
Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine.
- Published in:
- Gastric Cancer, 2008, v. 11, n. 4, p. 201, doi. 10.1007/s10120-008-0484-5
- By:
- Publication type:
- Article
EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition.
- Published in:
- International Journal of Oncology, 2015, v. 47, n. 2, p. 499, doi. 10.3892/ijo.2015.3050
- By:
- Publication type:
- Article
Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparison.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 4, n. 4, p. 603, doi. 10.3892/mco.2016.769
- By:
- Publication type:
- Article
Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 7, p. 1059, doi. 10.1007/s00432-009-0752-8
- By:
- Publication type:
- Article
Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experience.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 8, p. 1117, doi. 10.1007/s00432-009-0553-0
- By:
- Publication type:
- Article
Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil.
- Published in:
- International Journal of Cancer, 2008, v. 122, n. 9, p. 2148, doi. 10.1002/ijc.23381
- By:
- Publication type:
- Article
Phase II Study of Concurrent Chemoradiotherapy at the Dose of 50.4 Gy with Elective Nodal Irradiation for Stage II–III Esophageal Carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 6, p. 608, doi. 10.1093/jjco/hyt048
- By:
- Publication type:
- Article
Multicenter Feasibility Study of Combination Therapy with Fluorouracil, Leucovorin and Paclitaxel (FLTAX) for Peritoneal Disseminated Gastric Cancer with Massive Ascites or Inadequate Oral Intake.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 9, p. 787, doi. 10.1093/jjco/hys111
- By:
- Publication type:
- Article
A Phase I Trial of 5-Fluorouracil with Cisplatin and Concurrent Standard-dose Radiotherapy in Japanese Patients with Stage II/III Esophageal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 1, p. 37
- By:
- Publication type:
- Article
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1021, doi. 10.1007/s10637-022-01287-7
- By:
- Publication type:
- Article
An exploration of trifluridine/tipiracil in combination with irinotecan in patients with pretreated advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 3, p. 614, doi. 10.1007/s10637-022-01223-9
- By:
- Publication type:
- Article
Phase I study of the anti-heparin-binding epidermal growth factor-like growth factor antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 410, doi. 10.1007/s10637-019-00782-8
- By:
- Publication type:
- Article
Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 327, doi. 10.1634/theoncologist.2018-0119
- By:
- Publication type:
- Article
Recent Developments of Systemic Chemotherapy for Gastric Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1100, doi. 10.3390/cancers12051100
- By:
- Publication type:
- Article
Correction to: Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).
- Published in:
- Journal of Gastroenterology, 2021, v. 56, n. 3, p. 250, doi. 10.1007/s00535-020-01735-2
- By:
- Publication type:
- Article
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapies.
- Published in:
- Molecular Carcinogenesis, 2017, v. 56, n. 1, p. 106, doi. 10.1002/mc.22476
- By:
- Publication type:
- Article
Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2025, v. 30, n. 1, p. 17, doi. 10.1007/s10147-024-02652-7
- By:
- Publication type:
- Article
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1785, doi. 10.1007/s10147-024-02643-8
- By:
- Publication type:
- Article
Out-of-pocket fertility preservation expenses: data from a Japanese nationwide multicenter survey.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1959, doi. 10.1007/s10147-024-02614-z
- By:
- Publication type:
- Article
Defining the clinical benefits of adding a neurokinin-1 receptor antagonist to control chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a systematic review and meta-analysis of the clinical practice guidelines for antiemesis 2023 from the Japan society of clinical oncology
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1616, doi. 10.1007/s10147-024-02623-y
- By:
- Publication type:
- Article
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1632, doi. 10.1007/s10147-024-02624-x
- By:
- Publication type:
- Article
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 889, doi. 10.1007/s10147-024-02536-w
- By:
- Publication type:
- Article
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
- By:
- Publication type:
- Article
Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 355, doi. 10.1007/s10147-020-01802-x
- By:
- Publication type:
- Article
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 1, p. 1, doi. 10.1007/s10147-019-01485-z
- By:
- Publication type:
- Article